Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000351054 | SCV000335457 | uncertain significance | not provided | 2015-10-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001231363 | SCV001403883 | likely benign | Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) | 2022-12-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004021135 | SCV004859071 | uncertain significance | Inborn genetic diseases | 2023-10-05 | criteria provided, single submitter | clinical testing | The c.428C>T (p.A143V) alteration is located in exon 6 (coding exon 5) of the DNAJB6 gene. This alteration results from a C to T substitution at nucleotide position 428, causing the alanine (A) at amino acid position 143 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |